International Patent: METHODS FOR TREATING MESONEPHRIC CANCERS USING RAF/MEK INHIBITOR-FAK INHIBITOR COMBINATION THERAPY

GENEVA, Aug. 31 -- MEMORIAL SLOAN-KETTERING CANCER CENTER filed a patent application (US2026/016249) for “METHODS FOR TREATING MESONEPHRIC CANCERS USING RAF/MEK INHIBITOR-FAK INHIBITOR COMBINATION THERAPY”. With publication no. WO/2026/178490, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/353

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....